Literature DB >> 2763237

Anginal chest pain in sarcoidosis.

J L Wait1, A Movahed.   

Abstract

Of 43 consecutive black patients (42 male) with sarcoidosis, 12 (28%) complained of chest pain that met the clinical criteria for typical (four patients) or atypical (eight patients) angina pectoris. These patients underwent cardiopulmonary assessment, which included exercise and redistribution thallium-201 scans and, if indicated, coronary angiography. Nine control patients with sarcoidosis matched for age and duration of disease, but without chest pain, were also studied by thallium-201 scintigraphy. Six of the 12 patients with chest pain had thallium scans indicative of myocardial ischaemia, but all had normal coronary angiograms; no patient from the control group had evidence of ischaemia on the thallium scan. Four additional patients with chest pain and one from the control group had other (non-specific) abnormalities on the thallium scan, so that scans were abnormal in 10 of the 12 patients with sarcoidosis who had chest pain. Most patients with anginal chest pain reported partial or complete relief of symptoms with nitrates. Anginal chest pain appears to be common in black male patients with sarcoidosis, is associated with abnormal myocardial perfusion scans, and may result from myocardial sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763237      PMCID: PMC461840          DOI: 10.1136/thx.44.5.391

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease.

Authors:  B H Bulkley; J R Rouleau; J Q Whitaker; H W Strauss; B Pitt
Journal:  Chest       Date:  1977-07       Impact factor: 9.410

2.  Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Authors:  R J Knudson; M D Lebowitz; C J Holberg; B Burrows
Journal:  Am Rev Respir Dis       Date:  1983-06

Review 3.  Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging.

Authors:  S E Epstein
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

4.  Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographic implications in patients with coronary artery disease.

Authors:  C A Boucher; L M Zir; G A Beller; R D Okada; K A McKusick; H W Strauss; G M Pohost
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

5.  The anaerobic threshold measurement in exercise testing.

Authors:  K Wasserman
Journal:  Clin Chest Med       Date:  1984-03       Impact factor: 2.878

6.  Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.

Authors:  W P Follansbee; E I Curtiss; T A Medsger; V D Steen; B F Uretsky; G R Owens; G P Rodnan
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

7.  Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients.

Authors:  E L Kinney; G L Jackson; W C Reeves; R Zelis
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

8.  Detection of myocardial sarcoidosis by thallium 201 imaging.

Authors:  L J Haywood; O P Sharma; M E Siegel; R J Siegel; S L Gottlieb; J Caldwell; J K Siemsen
Journal:  J Natl Med Assoc       Date:  1982-10       Impact factor: 1.798

9.  Redistribution on the thallium scan in myocardial sarcoidosis: concise communication.

Authors:  P T Makler; S J Lavine; B S Denenberg; A A Bove; S Idell
Journal:  J Nucl Med       Date:  1981-05       Impact factor: 10.057

10.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

View more
  6 in total

Review 1.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

2.  Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies.

Authors:  Andreas A Giannopoulos; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2022-08-01       Impact factor: 3.872

3.  Is there an association between sarcoidosis and atherosclerosis?

Authors:  Yusuf Yilmaz; Seref Kul; Murat Kavas; Hayriye Erman; Gonul Aciksari; Fatma Betul Ozcan; Emre Yalcinkaya; Asiye Kanbay; Mustafa Caliskan
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-29       Impact factor: 2.357

4.  A case of cardiac sarcoidosis presenting with double tachycardia.

Authors:  Keiko Takahashi; Yasuo Okumura; Ichiro Watanabe; Koichi Nagashima; Hiroaki Mano; Kazumasa Sonoda; Rikitake Kogawa; Naoko Sasaki; Kazuki Iso; Kimie Okubo; Toshiko Nakai; Atsushi Hirayama
Journal:  J Arrhythm       Date:  2014-06-27

Review 5.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

6.  Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia.

Authors:  Elliott D Crouser; Mark W Julian; Sabahattin Bicer; Vikas Ghai; Taek-Kyun Kim; Lisa A Maier; May Gillespie; Nabeel Y Hamzeh; Kai Wang
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.